E-LIB Suche - Ergebnisse für: Choudhury, Lubna

1

The Clinical Impact of SARS-CoV-2 on Hypertrophic Cardiomyo..:

Saleh, Danish ; Meng, Zhiying ; Johnson, Nicholas...
Journal of Cardiovascular Development and Disease. 11 (2024) 4 - p. 104 , 2024

Link: https://doi.org/10.3390/..

2

Baseline Characteristics of Patients in SEQUOIA-HCM: A Phas..:

Maron, Martin S. ; Abraham, Theodore P. ; Coats, Caroline J....
Journal of Cardiac Failure. 30 (2024) - p. S3 , 2024

Link: https://doi.org/10.1016/..

3

Safety and Efficacy of Metabolic Modulation With Ninerafaxs..:

Maron, Martin S. ; Mahmod, Masliza ; Abd Samat, Azlan Helmy...
Journal of the American College of Cardiology. 83 (2024) 21 - p. 2037-2048 , 2024

Link: https://doi.org/10.1016/..

4

Effect of Aficamten on Structure and Function in Patients w..:

Masri, Ahmad ; Cardoso, Rhanderson ; Abraham, Theodore...
Journal of Cardiovascular Magnetic Resonance. 26 (2024) - p. 100772 , 2024

Link: https://doi.org/10.1016/..

5

Reduction of Filamin C Results in Altered Proteostasis, Car..:

Ohiri, Joyce C. ; Dellefave‐Castillo, Lisa ; Tomar, Garima...
Journal of the American Heart Association. 13 (2024) 10 - p. , 2024

Link: https://doi.org/10.1161/..

6

Mavacamten Treatment for Symptomatic Obstructive Hypertroph..:

Rader, Florian ; Oręziak, Artur ; Choudhury, Lubna...
JACC: Heart Failure. 12 (2024) 1 - p. 164-177 , 2024

Link: https://doi.org/10.1016/..

7

Exercise Capacity in Patients With Obstructive Hypertrophic..:

Coats, Caroline J. ; Maron, Martin S. ; Abraham, Theodore P....
JACC: Heart Failure. 12 (2024) 1 - p. 199-215 , 2024

Link: https://doi.org/10.1016/..

8

Efficacy and Safety of Aficamten in Symptomatic Nonobstruct..:

MASRI, AHMAD ; SHERRID, MARK V. ; ABRAHAM, THEODORE P....
Journal of Cardiac Failure. , 2024

Link: https://doi.org/10.1016/..

9

Cumulative long-term efficacy and safety of mavacamten trea..:

Owens, Anjali ; Sherrid, Mark ; Rader, Florian...
Journal of Cardiac Failure. 30 (2024) - p. S2-S3 , 2024

Link: https://doi.org/10.1016/..

10

Aficamten for Drug-Refractory Severe Obstructive Hypertroph..:

OWENS, ANJALI T. ; MASRI, AHMAD ; ABRAHAM, THEODORE P....
Journal of Cardiac Failure. 29 (2023) 11 - p. 1576-1582 , 2023

Link: https://doi.org/10.1016/..

11

Efficacy And Safety Of Aficamten In Patients With Symptomat..:

Masri, Ahmad ; Abraham, Theodore P. ; Choudhury, Lubna...
Journal of Cardiac Failure. 29 (2023) 4 - p. 554 , 2023

Link: https://doi.org/10.1016/..

12

Phase 2 Study of Aficamten in Patients With Obstructive Hyp..:

Maron, Martin S. ; Masri, Ahmad ; Choudhury, Lubna...
Journal of the American College of Cardiology. 81 (2023) 1 - p. 34-45 , 2023

Link: https://doi.org/10.1016/..

13

Fibrosis in Hypertrophic Cardiomyopathy Patients With and W..:

Vullaganti, Sirish ; Levine, Jonathan ; Raiker, Nisha...
Heart, Lung and Circulation. 30 (2021) 10 - p. 1496-1501 , 2021

Link: https://doi.org/10.1016/..

14

Direct mitral regurgitation quantification in hypertrophic ..:

Gupta, Aakash N. ; Avery, Ryan ; Soulat, Gilles...
Journal of Cardiovascular Magnetic Resonance. 23 (2021) 1 - p. 138 , 2021

Link: https://doi.org/10.1186/..

15

4D flow MRI left atrial kinetic energy in hypertrophic card..:

Gupta, Aakash N. ; Soulat, Gilles ; Avery, Ryan...
The International Journal of Cardiovascular Imaging. 37 (2021) 9 - p. 2755-2765 , 2021

Link: https://doi.org/10.1007/..